All stock lists
Alx Oncology Holdings Inc (NASDAQ:ALXO)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
1.14-0.04 (-2.99%)
Insider Score
––Not scored
ALXO Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
ALXO Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 150.00 K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | -150.00 K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 5.13 M | 5.36 M | 5.38 M | 5.09 M | 5.45 M | 7.93 M |
| R&D Expense | 13.14 M | 13.61 M | 17.64 M | 17.44 M | 18.02 M | 23.89 M |
| Operating Expenses | 18.03 M | 18.82 M | 23.02 M | 22.53 M | 26.65 M | 31.82 M |
| Operating Income | -18.03 M | -18.97 M | -23.02 M | -22.53 M | -26.65 M | -31.82 M |
| Pretax Income | -17.97 M | -17.93 M | -22.85 M | -22.14 M | -25.95 M | -30.75 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -17.97 M | -17.93 M | -22.85 M | -22.14 M | -25.95 M | -30.75 M |
| EPS (Basic) | -0.13 | -0.17 | -0.42 | -0.41 | -0.49 | -0.58 |
| EPS (Diluted) | -0.13 | -0.17 | -0.42 | -0.41 | -0.49 | -0.58 |
| Shares Outstanding | 135.64 M | 104.57 M | 54.28 M | 53.58 M | 53.45 M | 53.36 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.